Back to Search
Start Over
Primary Progressive Aphasia Associated With GRN Mutations: New Insights Into the Nonamyloid Logopenic Variant
- Source :
- Neurology, Neurology, 2021, 97 (1), pp.e88-e102. ⟨10.1212/wnl.0000000000012174⟩, Neurology, American Academy of Neurology, 2021, ⟨10.1212/wnl.0000000000012174⟩
- Publication Year :
- 2021
-
Abstract
- ObjectiveTo determine relative frequencies and linguistic profiles of primary progressive aphasia (PPA) variants associated with GRN (progranulin) mutations and to study their neuroanatomic correlates.MethodsPatients with PPA carrying GRN mutations (PPA-GRN) were selected among a national prospective research cohort of 1,696 patients with frontotemporal dementia, including 235 patients with PPA. All patients with amyloid-positive CSF biomarkers were excluded. In this cross-sectional study, speech/language and cognitive profiles were characterized with standardized evaluations, and gray matter (GM) atrophy patterns using voxel-based morphometry. Comparisons were performed with controls and patients with sporadic PPA.ResultsAmong the 235 patients with PPA, 45 (19%) carried GRN mutations, and we studied 32 of these. We showed that logopenic PPA (lvPPA) was the most frequent linguistic variant (n = 13, 41%), followed by nonfluent/agrammatic (nfvPPA; n = 9, 28%) and mixed forms (n = 8, 25%). Semantic variant was rather rare (n = 2, 6%). Patients with lvPPA, qualified as nonamyloid lvPPA, presented canonical logopenic deficit. Seven of 13 had a pure form; 6 showed subtle additional linguistic deficits not fitting criteria for mixed PPA and hence were labeled as logopenic-spectrum variant. GM atrophy involved primarily left posterior temporal gyrus, mirroring neuroanatomic changes of amyloid-positive-lvPPA. Patients with nfvPPA presented agrammatism (89%) rather than apraxia of speech (11%).ConclusionsThis study shows that the most frequent PPA variant associated with GRN mutations is nonamyloid lvPPA, preceding nfvPPA and mixed forms, and illustrates that the language network may be affected at different levels. GRN testing is indicated for patients with PPA, whether familial or sporadic. This finding is important for upcoming GRN gene–specific therapies.
- Subjects :
- Oncology
medicine.medical_specialty
Apraxia
050105 experimental psychology
Primary progressive aphasia
03 medical and health sciences
Dementia aphasia
0302 clinical medicine
Atrophy
Gyrus
Aphasia
Agrammatism
Internal medicine
medicine
0501 psychology and cognitive sciences
Prospective cohort study
business.industry
05 social sciences
respiratory system
medicine.disease
medicine.anatomical_structure
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Neurology (clinical)
medicine.symptom
business
030217 neurology & neurosurgery
Frontotemporal dementia
Subjects
Details
- Language :
- English
- ISSN :
- 00283878 and 1526632X
- Database :
- OpenAIRE
- Journal :
- Neurology, Neurology, 2021, 97 (1), pp.e88-e102. ⟨10.1212/wnl.0000000000012174⟩, Neurology, American Academy of Neurology, 2021, ⟨10.1212/wnl.0000000000012174⟩
- Accession number :
- edsair.doi.dedup.....41a1675b61674df3fad3d411f7a7405e
- Full Text :
- https://doi.org/10.1212/wnl.0000000000012174⟩